VHAM
ACAD icon

Van Hulzen Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Van Hulzen Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-400
Closed -$7.34K – 319
2024
Q4 		$7.34K Sell
400
-99,381
-100% -$1.6M ﹤0.01% 813
2024
Q3 		$1.53M Buy
99,781
+8,296
+9% +$138K 0.11% 134
2024
Q2 		$1.49M Buy
91,485
+14,231
+18% +$230K 0.1% 134
2024
Q1 		$1.43M Sell
77,254
-1,396
-2% -$34.6K 0.09% 139
2023
Q4 		$2.46M Buy
78,650
+25,580
+48% +$611K 0.17% 94
2023
Q3 		$1.11M Buy
53,070
+24,180
+84% +$657K 0.09% 144
2023
Q2 		$692K Sell
28,890
-760
-3% -$16.9K 0.06% 148
2023
Q1 		$558K Buy
+29,650
New +$565K 0.05% 167

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return